Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
JMIR Cancer
|
April 15, 2017
Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
Raymond P Perez, Shanda Finnigan, Krupa Patel, et al.
Seminars in Oncology Nursing
|
April 9, 2020
National Cancer Institute: Restructuring to Support the Clinical Trials of the Future
Marjorie Good, Kathleen Castro, Andrea Denicoff, et al.
Frontiers in Oncology
|
April 16, 2019
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers
Charles A Kunos, Jacek Capala, Shanda Finnigan, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2021
Ocular adverse events in PD-1 and PD-L1 inhibitors
LeAnne Young, Shanda Finnigan, Howard Streicher, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
JAMA Oncology
|
December 26, 2025
Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents
Zoe E Quandt, Shanda Finnigan, Vanessa Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation Program
David M Dilts, Alan B Sandler, Steven K Cheng, et al.
Archives of Gerontology and Geriatrics
|
September 24, 2004
Prevalence of anemia in skilled-nursing home residents
Andrew S Artz, Dean Fergusson, Paul J Drinka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program
Abdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
JMIR Cancer
|
April 15, 2017
Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
Raymond P Perez, Shanda Finnigan, Krupa Patel, et al.
Seminars in Oncology Nursing
|
April 9, 2020
National Cancer Institute: Restructuring to Support the Clinical Trials of the Future
Marjorie Good, Kathleen Castro, Andrea Denicoff, et al.
Frontiers in Oncology
|
April 16, 2019
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers
Charles A Kunos, Jacek Capala, Shanda Finnigan, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2021
Ocular adverse events in PD-1 and PD-L1 inhibitors
LeAnne Young, Shanda Finnigan, Howard Streicher, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
JAMA Oncology
|
December 26, 2025
Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents
Zoe E Quandt, Shanda Finnigan, Vanessa Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation Program
David M Dilts, Alan B Sandler, Steven K Cheng, et al.
Archives of Gerontology and Geriatrics
|
September 24, 2004
Prevalence of anemia in skilled-nursing home residents
Andrew S Artz, Dean Fergusson, Paul J Drinka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program
Abdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, et al.
Page
of 1